Skip to main content

Table 3 The independent predictors of unknown and unfavorable intensive phase treatment outcome among patients treated for MDR-TB in Ethiopia, 2009–2014

From: Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study

Variables Unknown outcome
CRRR 95% CI ARRR 95% CI
Model of care
 Ambulatory 2.107 (1.386, 3.203) ** 3.158 (1.612, 6.185) **
 Hospitalized 1 1
Residence
 Urban 0.538 (0.361,0.803) ** 0.370 (0.199, 0.66) **
 Rural 1 1
TB Treatment supporter
 Yes 0.964 (0.634, 1.465) 0.022 (0.002, 0.231) **
 Unknown 3.383 (1.632, 7.012) ** 0.332 (0.083, 1.319)
 No 1 1
Resistances to:
 Four drugs (RHES) 0.293 (0.165,0.523) ** 0.741 (0.267, 2.059)
 Three drugs (RHE) 0.254 (0.106,0.609) ** 0.185 (0.03, 0.9426) *
 Two drugs (RH) 0.285 (0.178,0.457) ** 0.350 (0.177, 0.693) **
 One drug(R) 1 1
  unfavorable outcome
CRRR 95% CI ARRR 95%CI
Age 1.039 (1.022, 1.056) ** 1.047 (1.024, 1.072) **
History of hypokalemia
 Yes 0.567 (0.371, 0.867)** 0.512 (0.280, 0.939) *
 Unknown 1.548 (0.857, 2.797) 1.454 (0.499, 4.242)
 No 1 1
  1. CRRR = Crude Relative Risk Ratio, ARRR = Adjusted Relative Risk Ratio, *p value< 0.05;
  2. **P value< 0.01